# Multifunctional Polymer-Modified P-CaO2@Au@OVA@Cu@DHPs Nanoparticles Enhance SARS-CoV-2 mRNA Vaccine-Induced Immunity via the cGAS–STING Signaling Pathway

**Authors:** Yanle Zhi, Shengchao Wang, Haibo Zhang, Guimin Xue, Zhiqiang Zhang

PMC · DOI: 10.3390/polym17192636 · 2025-09-30

## TL;DR

Researchers developed a new nanoparticle platform that improves the effectiveness of SARS-CoV-2 mRNA vaccines by enhancing immune responses and sustained antigen release.

## Contribution

A novel multifunctional nanoparticle platform was developed that acts as both an adjuvant and delivery system for mRNA vaccines.

## Key findings

- The nanoparticles enhanced macrophage antigen uptake and antigen processing in vitro.
- In vivo, the nanoparticles induced higher IgG levels and long-term immunity through sustained antigen release.
- The platform showed robust adjuvant activity and potentiated both humoral and cellular immune responses.

## Abstract

The success of mRNA-based SARS-CoV-2 vaccines has been confirmed in both preclinical and clinical settings. However, the development of safe and efficient mRNA vaccine delivery platforms remains challenging. In this report, PBAE-G-B-SS-modified CaO2 nanofibers and Au@OVA@Cu@Dendrobium huoshanense polysaccharides were employed to establish novel self-assembling polymeric micelles (CaO2@Au@OVA@Cu@DHPs) capable of serving as both an adjuvant and a delivery system for mRNA vaccines. In vitro, CaO2@Au@OVA@Cu@DHPs nanoparticles (NPs) were conducive to effective macrophage antigen uptake and efficient antigen processing. In vivo, P-CaO2@Au@OVA@Cu@DHPs NP administration was associated with a reduction in the ovalbumin (OVA) release rate that was conducive to the sustained induction of long-term immunity and to the production of higher levels of different IgG subtypes, suggesting that these effects were attributable to enhanced antigen uptake by antigen-presenting cells. Overall, these present data highlight the promise of these P-CaO2@Au@OVA@Cu@DHPs NPs as an effective and safe platform amenable to vaccine delivery through their ability to provide robust adjuvant activity and sustained antigen release capable of eliciting long-term immunological memory while potentiating humoral and cellular immune responses.

## Linked entities

- **Diseases:** SARS-CoV-2 (MONDO:0100096)

## Full-text entities

- **Genes:** STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}
- **Chemicals:** P (MESH:D010758), Au@OVA@Cu@Dendrobium huoshanense polysaccharides (-), CaO2 (MESH:C403632), Polymer (MESH:D011108)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12526564/full.md

---
Source: https://tomesphere.com/paper/PMC12526564